Raymond James Downgrades Omega Therapeutics(OMGA.US) to Hold Rating
Piper Sandler Maintains Omega Therapeutics(OMGA.US) With Buy Rating, Cuts Target Price to $4
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Omega Therapeutics Price Target Maintained With a $12.00/Share by Wedbush
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Buy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial Performance
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Buy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical Trials
Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9
Omega Therapeutics (OMGA) Receives a Buy From Piper Sandler
Omega Therapeutics Analyst Ratings
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
Buy Rating on Omega Therapeutics: Innovative Obesity Treatment Through Strategic Novo Nordisk Collaboration